The board of directors of WLS Holdings Limited announced that on September 27, 2021, the company entered into a strategic cooperation agreement with Zhejiang Hengting Biotechnology Limited (Hengting Biotechnology). According to the strategic cooperation agreement, both parties have reached a preliminary cooperation in sales, joint development or adopt other forms of cooperation in the construction of an innovative ecosystem of resources for the national health industry, combining the production capacity of major pharmaceutical companies, the terminal support of the health base, as well as sales and product expertise at an appropriate time. Both parties will develop a comprehensive strategic cooperation based on the principle of long-term strategic cooperation, including but not limited to equity investment, debt investment and other investments. Both parties will continue to expand the scope of cooperation according to market conditions and may hold senior management meetings from time to time to discuss the mode, direction and progress of the cooperation and other matters relating to the cooperation projects.